Singular Genomics Systems (OMIC) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free OMIC Stock Alerts $0.39 -0.02 (-4.92%) (As of 02:49 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Singular Genomics Systems Short Interest DataCurrent Short Volume732,300 sharesPrevious Short Volume813,500 sharesChange Vs. Previous Month-9.98%Dollar Volume Sold Short$376,548.66Short Interest Ratio / Days to Cover7.1Last Record DateMarch 31, 2024Outstanding Shares74,080,000 sharesFloat Size42,420,000 sharesShort Percent of Float1.73%Today's Trading Volume24,670 sharesAverage Trading Volume115,532 sharesToday's Volume Vs. Average21% Short Selling Singular Genomics Systems ? Sign up to receive the latest short interest report for Singular Genomics Systems and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOMIC Short Interest Over TimeOMIC Days to Cover Over TimeOMIC Percentage of Float Shorted Over Time Ad True Market InsidersExposed: 10 CENT Crypto to Explode April 20th?Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than BitcoinClick For My #1 FREE Crypto for 2024 Singular Genomics Systems Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024732,300 shares $376,548.66 -10.0%1.7%7.1 $0.51 3/15/2024813,500 shares $406,750.00 +7.3%1.9%6.5 $0.50 2/29/2024757,900 shares $432,003.00 -7.5%1.8%5.1 $0.57 2/15/2024819,000 shares $449,631.00 -5.9%2.0%4.9 $0.55 1/31/2024870,200 shares $439,451.00 -4.5%2.1%1.5 $0.51 1/15/2024911,200 shares $396,372.00 -17.2%2.2%1.6 $0.44 Get the Latest News and Ratings for OMIC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Singular Genomics Systems and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,100,000 shares $506,110.00 -5.2%2.6%1.9 $0.46 12/15/20231,160,000 shares $492,652.00 +3.6%2.8%2 $0.42 11/30/20231,120,000 shares $438,816.00 -27.3%2.7%1.9 $0.39 11/15/20231,540,000 shares $608,300.00 +40.0%3.7%2.6 $0.40 10/31/20231,100,000 shares $365,750.00 +8.9%2.7%2.3 $0.33 10/15/20231,010,000 shares $379,255.00 +3.4%2.5%4.2 $0.38 9/30/2023977,300 shares $372,351.30 +1.2%2.4%4.3 $0.38 9/15/2023965,800 shares $404,766.78 -3.3%2.4%3 $0.42 8/31/2023998,600 shares $469,242.14 +5.2%2.1%3.2 $0.47 8/15/2023949,400 shares $508,403.70 +1.7%2.0%3 $0.54 7/31/2023933,600 shares $740,251.44 +3.0%2.1%3.1 $0.79 7/15/2023906,200 shares $821,379.68 -0.1%2.0%3.2 $0.91 6/30/2023907,500 shares $753,225.00 -62.8%2.0%3.1 $0.83 6/15/20232,440,000 shares $2.08 million +10.9%5.5%8.3 $0.85 5/31/20232,200,000 shares $2.32 million +0.9%4.9%11.3 $1.06 5/15/20232,180,000 shares $1.95 million -0.9%4.9%12.1 $0.89 4/30/20232,200,000 shares $2.18 million +5.3%4.9%15 $0.99 4/15/20232,090,000 shares $2.15 million +3.0%4.7%14.8 $1.03 3/31/20232,030,000 shares $2.46 million +6.8%4.6%14.4 $1.21 3/15/20231,900,000 shares $2.43 million +8.6%4.3%14.1 $1.28 2/28/20231,750,000 shares $3.76 million -0.6%3.9%14.3 $2.15 2/15/20231,760,000 shares $4.24 million -10.2%4.0%15.3 $2.41 1/31/20231,960,000 shares $5.24 million -15.2%4.4%15.5 $2.68 1/15/20232,310,000 shares $4.87 million -3.4%5.3%17.1 $2.11 12/30/20222,390,000 shares $4.80 million -8.4%5.5%17 $2.01 12/15/20222,610,000 shares $5.87 million +1.6%6.4%15.6 $2.25 11/30/20222,570,000 shares $5.24 million -6.6%6.3%12.2 $2.04 11/15/20222,750,000 shares $6.57 million -2.8%7.7%12.1 $2.39 10/31/20222,830,000 shares $7.53 million -9.6%7.9%10.3 $2.66 10/15/20223,130,000 shares $7.26 million -2.8%8.8%11.4 $2.32 9/30/20223,220,000 shares $8.05 million +1.9%9.0%11.9 $2.50 9/15/20223,160,000 shares $10.59 million -3.4%8.9%10.2 $3.35 8/31/20223,270,000 shares $8.73 million +5.1%9.2%11.3 $2.67 8/15/20223,110,000 shares $13.40 million +12.3%8.4%8.8 $4.31top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… OMIC Short Interest - Frequently Asked Questions What is Singular Genomics Systems' current short interest? Short interest is the volume of Singular Genomics Systems shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 732,300 shares of OMIC short. 1.73% of Singular Genomics Systems' shares are currently sold short. Learn More on Singular Genomics Systems' current short interest. What is a good short interest ratio for Singular Genomics Systems? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OMIC shares currently have a short interest ratio of 7.0. Learn More on Singular Genomics Systems's short interest ratio. Which institutional investors are shorting Singular Genomics Systems? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Singular Genomics Systems: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Singular Genomics Systems? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.73% of Singular Genomics Systems' floating shares are currently sold short. Is Singular Genomics Systems' short interest increasing or decreasing? Singular Genomics Systems saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 732,300 shares, a decrease of 10.0% from the previous total of 813,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Singular Genomics Systems' float size? Singular Genomics Systems currently has issued a total of 74,080,000 shares. Some of Singular Genomics Systems' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Singular Genomics Systems currently has a public float of 42,420,000 shares. How does Singular Genomics Systems' short interest compare to its competitors? 1.73% of Singular Genomics Systems' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Singular Genomics Systems: Cue Health Inc. (0.52%), Cara Therapeutics, Inc. (5.56%), Rapid Micro Biosystems, Inc. (0.31%), Accelerate Diagnostics, Inc. (2.25%), Bionano Genomics, Inc. (9.78%), Talis Biomedical Co. (0.80%), Telesis Bio, Inc. (1.14%), Precipio, Inc. (0.39%), Seer, Inc. (5.99%), MiNK Therapeutics, Inc. (0.42%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Singular Genomics Systems stock? Short selling OMIC is an investing strategy that aims to generate trading profit from Singular Genomics Systems as its price is falling. OMIC shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Singular Genomics Systems? A short squeeze for Singular Genomics Systems occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OMIC, which in turn drives the price of the stock up even further. How often is Singular Genomics Systems' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OMIC, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Cue Health Short Interest Data Cara Therapeutics Short Interest Data Rapid Micro Biosystems Short Interest Data Accelerate Diagnostics Short Interest Data Bionano Genomics Short Interest Data Talis Biomedical Short Interest Data Telesis Bio Short Interest Data Precipio Short Interest Data Seer Short Interest Data MiNK Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OMIC) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals